Seeking Alpha

Alexza Pharmaceuticals (ALXA) says the FDA has accepted a resubmitted ADASUVE New Drug...

Alexza Pharmaceuticals (ALXA) says the FDA has accepted a resubmitted ADASUVE New Drug Application as a complete, class 2 response to the FDA's action letter, with an indicated Prescription Drug User Fee Act goal date of December 21, 2012. Shares -2.5% AH.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs